RxDoctor Payments Data

Jean Marie Ruddy, MD

Vascular Surgery · Charleston, SCNPI 1770665796

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $39,600 of the $54,011 with a category attached, or 73.3%. Cvrx, Inc. accounts for 95.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $21,247 and has fallen 75.7% since, to $5,170 in 2025.

$54,011in general payments, 2019–2025

Across 108 payments — averaging $500.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cvrx, Inc.$51K
  • W. L. Gore & Associates, Inc.$1K
  • Cook Medical LLC$448
  • Medtronic$294
  • Innovation Technologies Inc$156
  • KCI USA, Inc.$112
  • plus $404 from 5 others
$155,570in research payments, 2019–2025

Across 23 payments — averaging $6763.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cvrx, Inc.$156K

What the payments were for

  • Consulting fees$39,60073%
  • Travel & lodging$9,84118%
  • Food & beverage$4,5698%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,011 in reported general payments places this provider in the 85th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$91,171
Medicare patients
945
Services billed
1,208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →